Loading…
Lobbying Spend
—
Filings
15
Firms Hired
1
Active Period
2017–2024
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · fourth_quarter · Firm: CAPITOL COUNSEL LLC
Regulation of Ethylene Oxide; H.R. 2369 VALID Act of 2023; H.R. 1691 the Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1691
Regulation of Ethylene Oxide; H.R. 2369 VALID Act of 2023; H.R. 1691 the Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2369
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · third_quarter · Firm: CAPITOL COUNSEL LLC
Regulation of Ethylene Oxide; H.R. 2369 VALID Act of 2023; H.R. 1691 the Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1691
Regulation of Ethylene Oxide; H.R. 2369 VALID Act of 2023; H.R. 1691 the Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2369
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · second_quarter · Firm: CAPITOL COUNSEL LLC
Regulation of Ethylene Oxide; H.R. 2369 VALID Act of 2023; H.R. 1691 the Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1691
Regulation of Ethylene Oxide; H.R. 2369 VALID Act of 2023; H.R. 1691 the Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2369
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2024 · first_quarter · Firm: CAPITOL COUNSEL LLC
Regulation of Ethylene Oxide; H.R. 2369 VALID Act of 2023; H.R. 1691 the Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1691
Regulation of Ethylene Oxide; H.R. 2369 VALID Act of 2023; H.R. 1691 the Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2369
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2023 · fourth_quarter · Firm: CAPITOL COUNSEL LLC
Regulation of Ethylene Oxide; H.R. 2369 VALID Act of 2023; H.R. 1691 the Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1691
Regulation of Ethylene Oxide; H.R. 2369 VALID Act of 2023; H.R. 1691 the Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2369
Ensuring Patient Access to Critical Breakthrough Products Act of 2024
2023 · third_quarter · Firm: CAPITOL COUNSEL LLC
Regulation of Ethylene Oxide; H.R. 2369 VALID Act of 2023; H.R. 1691 the Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 1691
Regulation of Ethylene Oxide; H.R. 2369 VALID Act of 2023; H.R. 1691 the Ensuring Patient Access to Critical Breakthrough Products Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2369
Regulation of Ethylene Oxide; H.R. 2369 VALID Act of 2023.
Client expense: — · Firm income: $50,000
Matched citations: H.R. 2369
Medical Device User Fee (MDUFA) Reauthorization legislation; H.R. 2369 VALID Act of 2023.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2369
U.S.-Greece Defense and Interparliamentary Partnership Act of 2021
2022 · fourth_quarter · Firm: CAPITOL COUNSEL LLC
Medical Device User Fee (MDUFA) Reauthorization legislation; HR 4129/S.2209 VALID Act of 2021.
Client expense: — · Firm income: $70,000
Matched citations: HR 4129
Medical Device User Fee (MDUFA) Reauthorization legislation; HR 4129/S.2209 VALID Act of 2021.
Client expense: — · Firm income: $70,000
Matched citations: S.2209
U.S.-Greece Defense and Interparliamentary Partnership Act of 2021
2022 · third_quarter · Firm: CAPITOL COUNSEL LLC
Medical Device User Fee (MDUFA) Reauthorization legislation; HR 4129/S.2209 VALID Act of 2021.
Client expense: — · Firm income: $60,000
Matched citations: HR 4129
Medical Device User Fee (MDUFA) Reauthorization legislation; HR 4129/S.2209 VALID Act of 2021.
Client expense: — · Firm income: $60,000
Matched citations: S.2209
U.S.-Greece Defense and Interparliamentary Partnership Act of 2021
2022 · third_quarter · Firm: CAPITOL COUNSEL LLC
Medical Device User Fee (MDUFA) Reauthorization legislation; HR 4129/S.2209 VALID Act of 2021.
Client expense: — · Firm income: —
Matched citations: HR 4129
Medical Device User Fee (MDUFA) Reauthorization legislation; HR 4129/S.2209 VALID Act of 2021.
Client expense: — · Firm income: —
Matched citations: S.2209
Source: Senate LDA